TABLE 4.

Outcomes to TKI in combination with ALL chemotherapy in lymphoid BP‐CML

Combination	Reference(s)	No. of patients	CHR (%)	CCyR (%)	alloHSCT (%)	Median OS (mo)
Imatinib + vincristine + dexamethasone	58	12	91.7	33.3	58.3	13
Imatinib or dasatinib + HyperCVAD	56	42	90.4	58	42.9	17

Abbreviations: alloHSCT, allogeneic haemopoietic stem cell transplantation; CCyR, complete cytogenetic remission; CHR, complete haematologic remission; HyperCVAD, hyperfractionated cyclophosphamide, vincristine, adriamycin and dexamethasone; OS, overall survival.